SFPIM, as Belgium's sovereign wealth fund, focuses its investments on strategically important Belgian companies and sectors, including historical areas like life sciences, finance, and aviation, alongside emerging sectors such as energy & utilities, transport & mobility, and impact investing. Its strategy emphasizes a balance between financial profitability and societal relevance, aiming to foster economic growth, stability, and sustainable development within Belgium.
50% of their portfolio is in Biotech & Life Sciences. Deal activity increased 200% year-over-year (3 deals in the last 12 months). Average disclosed round size is $43.0M (across 3 rounds with reported amounts).
Portfolio
4
Fund Size
$18B
Top Stage
Series A
Last 12 Mo
3
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Axelera AI | Series C | — | Feb 2026 |
| AAidoptation | Unknown | $20M | Dec 2025 |
| MMRM Health | Series B | $55M | Sep 2025 |
 ATB Therapeutics | Series A | $54M | Nov 2024 |
Top Co-Investors
Last updated: 10 April 2026